Accretion Pharmaceuticals
add_icon

Accretion Pharmaceuticals

119.55
-1.85
(-1.52%)
Market Cap
132.89 Cr
PE Ratio
13.95
Volume
25,200.00
Day High - Low
123.35 - 118.00
52W High-Low
127.00 - 53.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
132.89 Cr
EPS
9.03
PE Ratio
13.95
PB Ratio
2.47
Book Value
49.21
EBITDA
14.95
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
44.44
Debt to Equity
1.33
Forecast For
Actual

Company News

View All News
Caret
positive
Accretion Pharmaceuticals filed its FY26 media release under Regulation 30, reporting net revenue of ₹89.63 crore, up 56.21% YoY, and PAT of ₹9.67 crore, up 42.30% YoY.
neutral
Accretion Pharmaceuticals submits Structured Digital Database Compliance Certificate for FY ended 31st March, 2026, confirming full SEBI insider trading regulation adherence.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,878.20
#1 4,50,643.09
40.81
#1 54,729.00
9.71
#1 10,980
16.07
64.89
6,760.50
1,79,470.03
74.13
9,712.00
18.67
2,191
-1.02
64.06
4,405.70
1,49,108.91
65.68
11,539.40
6.99
1,911
26.24
58.52
1,432.10
1,15,682.27
30.09
27,711.70
-2.46
3,783
-55.32
69.78
1,336.70
1,11,566.73
26.16
33,593.30
-0.44
3,998
-86.05
59.87
2,276.20
1,04,032.18
#1 19.28
27,487.50
19.98
5,345
#1 87.72
46.11
2,503.00
1,03,325.11
56.36
12,744.20
20.90
2,007
7.65
73.37
1,011.70
1,01,800.69
19.85
23,511.00
18.55
4,615
-0.32
69.47
1,511.80
87,805.59
25.16
32,345.60
9.43
3,484
7.59
73.83
1,323.60
71,455.42
79.78
6,812.90
#1 21.03
884
21.18
80.26
Growth Rate
Revenue Growth
55.88 %
Net Income Growth
43.24 %
Cash Flow Change
149.96 %
ROE
63.50 %
ROCE
248.60 %
EBITDA Margin (Avg.)
-20.15 %

Yearly Financial Results

Annual Financials
2024
2025
2026
TTM
Revenue
13
58
90
0
Expenses
11
46
75
0
EBITDA
3
12
15
0
Operating Profit %
19 %
21 %
17 %
0 %
Depreciation
0
1
1
0
Interest
0
1
1
0
Profit Before Tax
2
10
13
0
Tax
1
3
3
0
Net Profit
2
7
10
0
EPS in ₹
1.96
8.48
9.03
0.00

Balance Sheet

Balance Sheet
2024
2025
2026
Total Assets
27
40
77
Fixed Assets
5
6
13
Current Assets
22
34
61
Capital Work in Progress
0
0
0
Investments
0
0
28
Other Assets
22
34
0
Total Equity & Liabilities
27
40
77
Current Liabilities
15
23
21
Non Current Liabilities
7
1
1
Total Equity
6
15
55
Reserve & Surplus
2
7
44
Share Capital
4
8
11

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
0
Investing Activities
-6
-2
Operating Activities
-12
6
Financing Activities
17
-4

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
100.00 %
100.00 %
73.50 %
73.50 %
73.52 %
73.52 %
73.52 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
21.46 %
22.85 %
22.01 %
22.92 %
Others
0.00 %
0.00 %
7.06 %
5.04 %
3.63 %
4.47 %
3.56 %
No of Share Holders
8
8
8
1,628
1,498
1,179
1,182

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jun 2025 66.05 69.80
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 56.75 66.15
08 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2026 108.65 112.50

Technical Indicators

RSI(14)
Neutral
72.84
ATR(14)
Less Volatile
6.06
STOCH(9,6)
Overbought
90.70
STOCH RSI(14)
Neutral
59.83
MACD(12,26)
Bullish
1.44
ADX(14)
Strong Trend
48.83
UO(9)
Bearish
70.16
ROC(12)
Uptrend And Accelerating
29.22
WillR(14)
Overbought
-14.81